title: Virus-specific regulatory T cells ameliorate encephalitis by repressing effector T cell functions from priming to effector stages.
abstract: Several studies have demonstrated the presence of pathogen-specific Foxp3+ CD4 regulatory T cells (Treg) in infected animals, but little is known about where and how these cells affect the effector T cell responses and whether they are more suppressive than bulk Treg populations. We recently showed the presence of both epitope M133-specific Tregs (M133 Treg) and conventional CD4 T cells (M133 Tconv) in the brains of mice with coronavirus-induced encephalitis. Here, we provide new insights into the interactions between pathogenic Tconv and Tregs responding to the same epitope. M133 Tregs inhibited the proliferation but not initial activation of M133 Tconv in draining lymph nodes (DLN). Further, M133 Tregs inhibited migration of M133 Tconv from the DLN. In addition, M133 Tregs diminished microglia activation and decreased the number and function of Tconv in the infected brain. Thus, virus-specific Tregs inhibited pathogenic CD4 T cell responses during priming and effector stages, particularly those recognizing cognate antigen, and decreased mortality and morbidity without affecting virus clearance. These cells are more suppressive than bulk Tregs and provide a targeted approach to ameliorating immunopathological disease in infectious settings.
authors.affiliation: Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
authors.forename: Jingxian
authors.initials: J
authors.lastname: Zhao
authors.affiliation: Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
authors.forename: Jincun
authors.initials: J
authors.lastname: Zhao
authors.affiliation: Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
authors.forename: Stanley
authors.initials: S
authors.lastname: Perlman
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003333:Coronaviridae Infections / Q000276:immunology*; D004195:Disease Models, Animal; D018792:Encephalitis, Viral / Q000276:immunology*; D005434:Flow Cytometry; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
references.citation: J Exp Med. 2010 Jul 5;207(7):1409-20
references.pmid: 20547826
references.citation: J Immunol. 2004 Apr 1;172(7):4123-32
references.pmid: 15034024
references.citation: J Virol. 1995 Dec;69(12):8127-31
references.pmid: 7494335
references.citation: PLoS Pathog. 2010 Aug 12;6(8):e1001043
references.pmid: 20714351
references.citation: J Immunol. 2004 Sep 1;173(5):2942-51
references.pmid: 15322152
references.citation: Immunity. 2009 May;30(5):636-45
references.pmid: 19464986
references.citation: J Virol. 2009 Apr;83(7):3019-28
references.pmid: 19153229
references.citation: J Biol Chem. 2006 Apr 28;281(17):11992-2000
references.pmid: 16473879
references.citation: PLoS One. 2012;7(9):e46241
references.pmid: 23029447
references.citation: J Exp Med. 2011 Aug 1;208(8):1571-7
references.pmid: 21746812
references.citation: Immunity. 2009 Nov 20;31(5):772-86
references.pmid: 19896394
references.citation: Immunol Rev. 2006 Aug;212:217-37
references.pmid: 16903917
references.citation: Nat Rev Immunol. 2008 Jul;8(7):523-32
references.pmid: 18566595
references.citation: Diabetes Care. 2012 Sep;35(9):1817-20
references.pmid: 22723342
references.citation: J Exp Med. 2004 Jun 7;199(11):1455-65
references.pmid: 15184499
references.citation: J Immunol. 2013 Jun 15;190(12):6115-25
references.pmid: 23667113
references.citation: Science. 2008 May 30;320(5880):1220-4
references.pmid: 18436744
references.citation: J Immunol Methods. 2013 Oct 31;396(1-2):56-64
references.pmid: 23928495
references.citation: Immunity. 2013 Jun 27;38(6):1261-70
references.pmid: 23791647
references.citation: Am J Pathol. 2006 Jul;169(1):209-22
references.pmid: 16816374
references.citation: Nat Rev Drug Discov. 2010 Nov;9(11):883-97
references.pmid: 21031003
references.citation: Nat Med. 2007 Apr;13(4):423-31
references.pmid: 17384649
references.citation: Curr Opin Organ Transplant. 2012 Aug;17(4):349-54
references.pmid: 22790069
references.citation: Nat Rev Immunol. 2011 Feb;11(2):119-30
references.pmid: 21267013
references.citation: J Exp Med. 2006 Mar 20;203(3):777-88
references.pmid: 16533885
references.citation: J Immunol. 2000 Sep 1;165(5):2327-30
references.pmid: 10946253
references.citation: J Immunol. 2010 Apr 15;184(8):4391-400
references.pmid: 20208000
references.citation: J Clin Invest. 2009 Nov;119(11):3266-77
references.pmid: 19855131
references.citation: J Virol. 1986 Jun;58(3):869-75
references.pmid: 3701929
references.citation: J Virol. 2005 Sep;79(17):11335-42
references.pmid: 16103185
references.citation: J Virol. 2001 Mar;75(6):3043-7
references.pmid: 11222733
references.citation: Virology. 1995 Nov 10;213(2):482-93
references.pmid: 7491773
references.citation: Nat Immunol. 2009 Jun;10(6):595-602
references.pmid: 19412181
references.citation: Immunol Rev. 2013 Sep;255(1):182-96
references.pmid: 23947355
references.citation: Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14602-7
references.pmid: 21873213
references.citation: J Immunol. 2012 Dec 15;189(12):5924-33
references.pmid: 23129753
references.citation: Nat Rev Microbiol. 2006 Feb;4(2):121-32
references.pmid: 16415928
references.citation: J Immunol. 2012 Sep 15;189(6):2890-6
references.pmid: 22869903
references.citation: Virology. 2009 Mar 15;385(2):358-67
references.pmid: 19141357
references.citation: Immunity. 2008 Sep 19;29(3):362-71
references.pmid: 18799144
references.citation: J Exp Med. 2007 Jan 22;204(1):191-201
references.pmid: 17210729